Browsing by Subject "Chagas disease"
Now showing items 1-20 of 32
-
(Fundacao Oswaldo Cruz, 2002)Mepraia spinolai is a silvatic species of Triatominae which prefers microhabitats near to or in rock piles. It is also able to maintain similar or higher size populations near houses. The density of bugs in quarries near ...
-
(Elsevier, 2017)BACKGROUND Benznidazole is recommended for treatment of Chagas infection. Effects of combination therapy with benznidazole and posaconazole have not been tested in Trypanosoma cruzi carriers. OBJECTIVES The purpose of ...
-
(Society of Biology of Chile, 2010)There are approximately 7.8 million people in Latin America, including Chile, who suffer from Chagas disease and another 28 million who are at risk of contracting it. Chagas is caused by the flagellate protozoan Trypanosoma ...
-
Changes in age and geographic distribution of the risk of Chagas disease in Chile from 1989 to 2017 (Mary Ann Liebert, 2020)The interruption of vector-borne transmission of Chagas disease was certified in Chile in 1999. Our goal was to determine the effects of the interruption of vector transmission on the age and spatial distributions of the ...
-
(Elsevier B.V., 2019)© 2018 Elsevier B.V. Chagas disease is a vector-borne disease caused by the parasite Trypanosoma cruzi, and transmitted by triatomine insects to several mammal species. In Chile, the wild triatomine species are the endemic ...
-
(2010)Chagas disease must be treated in all its stages: acute, indeterminate, chronic, and initial and middle determinant chronic, due to the fact that DNA of the parasite can be demonstrated by PCR in chronic cases, where optical ...
-
(2011)Objectives: This study compared three parasitological methods applied simultaneously in individuals with untreated chronic Chagas' disease in order to determine their individual and combined performances. Methods: From a ...
-
(2011)Chagas disease has a variable clinical course with different manifestations and heterogenous geographical distribution. Some studies suggest that this clinical variability could be influenced by the genetic variability of ...
-
(Elsevier B.V., 2018)© 2018 Elsevier B.V. Chagas disease is a major public health problem in Latin America and has spread to other countries due to immigration of infected persons. 10–30% of patients with chronic Chagas disease will develop ...
-
(Blackwell Publishing Ltd, 2014)© 2014 The Royal Entomological Society. Several reports have described host species diversity and identity as the most important factors influencing disease risk, producing either dilution or amplification of the pathogen ...
-
(Springer, 2015)Chagas disease, caused by the protozoan Trypanosoma cruzi, is a major parasitic disease that affects millions of people in America. However, despite the high impact of this disease on human health, no effective and ...
-
(National Academy of Sciences, 1990)A panel of Trypanosoma cruzi antigens produced by recombinant DNA techniques was used to analyze the IgM and IgG specificities present in sera from 22 mothers with chronic Chagas disease and their newborn infants. Ten ...
-
(2006)Background: Insects of the subfamily triatominae are the biological vectors of Trypanosoma cruzi, the causal agent of Chagas disease. Aim: To search for wild colonies of triatomines in the Metropolitan Region of Chile. ...
-
(Expert Reviews, 2014)Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. This illness is now becoming global, mainly due to congenital transmission, and so far, there are no prophylactic or ...
-
(Elsevier, 2013)The hematophagous Hemiptera of the subfamily Triatominae are a very diverse group with a variety of morphs, behaviors and distributions. They have great epidemiological importance because many of its members are vectors ...
-
(Bentham Science Publishers Ltd., 2008)In order to get insight into the trypanocidal mechanism of action of a series of 5-nitrofuryl containing thiosemicarbazones some studies related to their bioreduction were performed. Electron spin resonance spectra of ...
-
(MARY ANN LIEBERT, 2016)Chagas disease, which ranks among the world's most neglected diseases, is a chronic, systemic, parasitic infection caused by the protozoan Trypanosoma cruzi. Mepraia species are the wild vectors of this parasite in Chile. ...
-
(2011)Chagas disease is one of the most important endemic diseases in Latin America, caused by Trypanosoma cruzi. The drugs used for the treatment of this disease, nifurtimox and benznidazole, are toxic and present severe side ...
-
(Elsevier, 2020)Chagas disease is a public health problem in America. Its parasite, Trypanosoma cruzi, presents different discrete typing units (DTUs), colonizes organs of mammalian hosts in chronic infections, and presents tropism for ...
-
(Elsevier, 2016)Benznidazole is the first-line drug used in treating Chagas disease, which is caused by the parasite Trypanosoma cruzi (T. cruzi). However, benznidazole has limited efficacy and several adverse reactions. Pentamidine is ...